Search Results - "Kallu, Jyothi"

Combination Therapy of NSCLC Using Hsp90 Inhibitor and Doxorubicin Carrying Functional Nanoceria by Sulthana, Shoukath, Banerjee, Tuhina, Kallu, Jyothi, Vuppala, Sudershini Reddy, Heckert, Blaze, Naz, Shuguftha, Shelby, Tyler, Yambem, Olivia, Santra, Santimukul

“…K-RAS driven non-small-cell lung cancer (NSCLC) represents a major cause of death among smokers. Recently, nanotechnology has introduced novel avenues for the…”
Get full text

Nanomedicine-Assisted Combination Therapy of NSCLC: New Platinum-Based Anticancer Drug Synergizes the Therapeutic Efficacy of Ganetespib by Kallu, Jyothi, Banerjee, Tuhina, Sulthana, Shoukath, Darji, Saloni, Higginbotham, Ryan, Fletcher, Christina, Gerasimchuk, Nikolay N, Santra, Santimukul

“…K-RAS is the most common mutated oncogene associated with Non-Small-Cell Lung Cancer (NSCLC). So far, there are no promising chemotherapies for the direct…”
Get full text

An activity-based fluorescent sensor for the detection of the phenol sulfotransferase SULT1A1 in living cells by Baglia, Regina A, Mills, Kira R, Mitra, Koushambi, Tutol, Jasmine N, Ball, Darby, Page, Kierstin M, Kallu, Jyothi, Gottipolu, Sriharika, D'Arcy, Sheena, Nielsen, Steven O, Dodani, Sheel C

“…Human phenol sulfotransferases mediate the transfer of a sulfuryl moiety from the activated sulfate donor PAPS to hydroxy-containing substrates, altering…”
Get full text